Helmut Gadner

Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study Group

Simon Cotterill, S. Ahrens, Michael Paulussen et al. · Journal of Clinical Oncology · 2000 · 1K citations

Medicine, Oncology, Chemotherapy +16

Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Leo Kager, A. Zoubek, Ulrike Pötschger et al. · Journal of Clinical Oncology · 2003 · 957 citations

Medicine, Oncology, Surgery +17

Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol

Helena Trottestam, AnnaCarin Horne, Maurizio Aricò et al. · Blood · 2011 · 677 citations · Full text

Medicine, Hematology, Oncology +14

MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration

Inge M. Ambros, Peter F. Ambros, Sabine Strehl et al. · Cancer · 1991 · 657 citations · Full text

Life Sciences, Genetics, Oncology +17

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Anja Möricke, Alfred Reiter, Martin Zimmermann et al. · Blood · 2008 · 610 citations · Full text

Medicine, Oncology, Pediatrics +14